Show simple item record

Summary Report on Carbapenemase Producing Enterobacterales (CPE) November 2024

dc.contributor.authorHealth Protection Surveillance Centre (HPSC)
dc.date.accessioned2025-01-07T14:14:31Z
dc.date.available2025-01-07T14:14:31Z
dc.date.issued2024-12-30
dc.identifier.urihttp://hdl.handle.net/10147/643840
dc.description• There were 122 new CPE patients identified in November 2024 as reported to the HSE acute hospital operations. The number of new cases of CPE detected increased from Q1 2024 to Q3 2024 but has fallen again since October. • 31,451 CPE surveillance samples were reported as tested in HSE laboratories in November 2024.The number of surveillance samples reported has increased over the past 3 quarters (Q1 2024 to Q3 2024). • The provisional total of new patients for November 2024 is 152 as reported to the National CPE Reference Laboratory Service (NCPERLS). The total for November 2023 was 85.en_US
dc.language.isoenen_US
dc.publisherHealth Service Executiveen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEpidemiologyen_US
dc.subjectPUBLIC HEALTHen_US
dc.subjectINFECTIOUS DISEASESen_US
dc.subjectCARBAPENEMASE PRODUCING ENTEROBACTERALES (CPE)en_US
dc.titleSummary Report on Carbapenemase Producing Enterobacterales (CPE) November 2024en_US
dc.typeReporten_US
dc.contributor.affiliationHealth Protection Surveillance Centre (HPSC)en
refterms.dateFOA2025-01-07T14:14:33Z


Files in this item

Thumbnail
Name:
Mth 11 AMRIC November 2024 CPE ...
Size:
557.0Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International